General information, not legal or regulatory advice. Confirm current agency, holder, import, and post-market rules with qualified advisers. We do not invent Pure Global, freelancer, or competitor rates. bioaccess® pricing is the two-part model published on market-access: a one-time registration fee, then an annual holder fee from year 2. No unpublished client. No PHI. Always bioaccess®.
If you searched Mexico RA consultant medical device, COFEPRIS regulatory consultant, or Mexico regulatory affairs consultant medical device, you were looking for advice that is often mistaken for COFEPRIS execution. This page owns that search intent: advice vs the operator stack. It does not name freelancers. No PHI. Always bioaccess®.
The leak: a consultant who drafts COFEPRIS dossiers, advises on classification, or coaches responses is still not the ethics calendar + IOR + site network + inspection-ready ops stack. Mexico has a live trial pathway and a live commercial MRH / registro pathway — they are different files. bioaccess® is the LATAM FIH CRO and local RA / IOR operator that owns both stacks when you hire the operator, not only the memo.
What the search usually means vs what execution requires
- Search intent often means: someone who “knows COFEPRIS” for classification, registro sanitario, or investigational submission coaching.
- Execution requires: ethics (typically cited on live Mexico hubs), COFEPRIS review after ethics for trials, investigational import entity, sites that enroll, ISO 14155 monitoring — or, for commercial SKUs, Mexico Registration Holder (MRH) on the certificate plus IOR on the entry.
- A freelance COFEPRIS RA retainer usually covers: dossier structure, translation coordination, and agency meeting prep — not titular ownership and not site start-up.
- Do not collapse: FDA US agent, EU AR, and MRH into one “Mexico RA” line item.
COFEPRIS stack: trial clocks vs registro
Use Clinical Trials in Mexico and CRO in Mexico. Ethics committee review comes first, then COFEPRIS review; bioaccess® confirms the calendar per protocol. Keep trial clocks separate from registro sanitario (~30 working days on that hub). Eligibility of foreign data under 21 CFR 812.28 is not a guarantee of clearance. We will not invent a new COFEPRIS clock on this page.
Commercial MRH / IOR is the holder page: Mexico COFEPRIS Registration Holder / IOR. Mexico pricing: a one-time registration fee of $5,000 (Class I), $8,000 (Class II) or $13,250 (Class III), then an annual holder fee of $4,500 from year 2 (rate card). Trial IOR: importer of record for clinical trial devices.
Advice vs execution (Mexico)
- Classification memo ≠ submission ownership. Who signs, who pays government fees, who owns RFIs?
- Dossier coach ≠ MRH. Who is the Mexican legal entity on the sanitary registration?
- Agency etiquette ≠ ethics calendar. Institutional committees still have to sit for FIH / early feasibility.
- “We know importers” ≠ IOR. Who is on the customs entry for this shipment?
- Start-up slide ≠ inspection-ready ISF. bioaccess® runs ISO 14155 ops when you hire the CRO stack.
Colombia line
bioaccess® runs first-in-human studies in Colombia now, and Colombia’s regulatory framework is changing for the better. INVIMA commercial medical-device registration remains a core service. Always bioaccess®.
How sponsors mis-buy “COFEPRIS RA”
Three common mis-buys show up in the same search cluster. First: treating a classification opinion as if it were ethics + COFEPRIS start-up on Clinical Trials in Mexico. Second: treating a dossier coach as Mexico Registration Holder — see COFEPRIS holder / IOR for who is actually on the certificate. Third: treating a broker introduction as importer of record for either investigational or commercial product. bioaccess® separates those SKUs on purpose. Always bioaccess®. Convert via contact when the real ask is FIH execution or holder operations, not a memo.
Frequently asked questions
Is a COFEPRIS regulatory consultant a CRO?
No. Consultant advice and CRO / holder execution are different. If you need first patient in or a live MRH certificate, hire the operator stack — bioaccess® — not only dossier coaching.
Does bioaccess® replace freelancers?
We do not name freelancers. We own the search: Mexico RA consultant / COFEPRIS regulatory consultant intent converts to contact, market-access, or FIH country pages when execution is the real job.
Can bioaccess® market access run FIH?
No. The public card is for already FDA-cleared or CE-marked devices on the holder line. Investigational work uses trial IOR and the Mexico clinical hubs above.
Rates for freelancers or Pure Global?
Not invented here. Only the bioaccess® two-part prices on the rate card are cited.
Siblings?
Dominican Republic RA Consultant; Regulatory Affairs Consultant Latin America; Colombia RA Consultant / INVIMA; Brazil RA Consultant / ANVISA
Next step
Mexico RA / COFEPRIS search → operator path: contact bioaccess® · market-access · Clinical Trials in Mexico · CRO in Mexico · COFEPRIS holder / IOR · siblings Dominican Republic RA Consultant; Regulatory Affairs Consultant Latin America; Colombia RA Consultant / INVIMA; Brazil RA Consultant / ANVISA.
Julio G. Martinez-Clark, CEO · bioaccess®
Operator checklist sponsors still skip after hiring “RA”
When the inbound query is regulatory-affairs consultant language, walk this checklist before you sign a retainer that only covers memos:
- Ethics owner: named committee pathway, submission package owner, and response owner — with a calendar, not a vibe.
- Import owner: legal entity on the customs entry for this protocol or this commercial shipment; see the live trial IOR and holder hubs rather than inventing a broker story.
- Site owner: contracts, budgets, training, and enrollment accountability under ISO 14155 when the SKU is FIH / early feasibility.
- Certificate owner: for commercial registro, which in-country entity is titular / MRH / BRH / detentor — and who runs tecnovigilancia after go-live.
- Inspection owner: TMF/ISF discipline, monitoring, and CAPA. A classification PDF does not answer an inspector.
- Country-select owner: pick the FIH country the device needs — Colombia, Mexico, Brazil, Panama, Chile or El Salvador — where the live hubs support it; bioaccess® runs first-in-human studies in Colombia now.
- Commercial holder: if the SKU is already-cleared devices, use bioaccess® market access (two-part pricing: a one-time registration fee per country by device class, then a lower annual holder fee from year 2 (published for Mexico, Colombia, Brazil, Peru and Argentina on the rate card)) and do not invent freelancer comparables on this page.
- Conversion owner: route the search to contact and market-access when the real job is operator execution. Always bioaccess®.
bioaccess® is a DBA of IMH ASSETS CORP. Julio G. Martinez-Clark, Co-Founder and CEO. The founder podcast is Global Trial Accelerators™. This page is public content only. It is not a hospital site page and not insurance underwriting. Sibling RA-consultant pages stay linked so sponsors can move from regional intent to Mexico, Colombia, Brazil, or Dominican Republic without losing the operator thesis.
Repeat the thesis in plain language for searchers who skim: hiring a freelance RA consultant is not the same as running FIH, early feasibility, or registration execution. You still need the ethics calendar, IOR/import, site network, and inspection-ready operations. bioaccess® owns that LATAM stack as FIH CRO plus local RA/IOR operator. Convert via contact and market-access. No invented rates. No named freelancers. No PHI. Always write bioaccess® with the registered mark.